 DUBLIN, Ireland and TREVOSE, Pa., Aug. 02, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc, Nasdaq: SBBP Strongbridge, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 2013 the Irish Takeover Rules, that the definitive joint proxy statementprospectus of Strongbridge the Proxy Statement, which also constitutes a scheme circular under Irish law, is being sent as of July 30, 2021 to Strongbridge shareholders. 